Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

PGR positive

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

HR positive (184)

HR negative (25)

ER positive + PGR positive (12)

HR positive + HER-2 negative (5)

ER positive + PGR negative (2)

FGFR1 overexpression + HR positive (2)

HR negative + PD-L1 expression (2)

HR positive + ER overexpression (2)

HR positive + HER-2 underexpression (2)

PGR expression (2)

PGR overexpression (2)

CETN2 overexpression + HR positive (1)

CETN2 overexpression + MLH3 overexpression + PCNA overexpression + HR positive (1)

ER positive + CDK6 overexpression (1)

ER positive + PGR negative + HER-2 negative (1)

HDC overexpression + HR positive (1)

HR overexpression (1)

HR positive + AR positive (1)

HR positive + BRCA positive (1)

HR positive + CCNE1 overexpression (1)

HR positive + ERBB3 overexpression (1)

HR positive + ERBB3 underexpression (1)

HR positive + HER-2 positive (1)

HR positive + PD-L1 expression (1)

HR positive + PLK1 overexpression (1)

HR positive + TNFRSF11A overexpression (1)

MLH3 overexpression + HR positive (1)

NOTCH3 expression + ER positive + PGR positive (1)

PCNA overexpression + HR positive (1)

PGR negative (1)

RAD51 overexpression + HR positive (1)

RFC3 overexpression + ER positive (1)

TNFRSF1A overexpression + HR positive (1)

TYMS overexpression + HR positive (1)

ER negative + PGR positive (0)

ER positive + PGR positive + HER-2 positive (0)

HER-2 negative + PGR positive (0)

HR negative + HER-2 positive (0)

MIEN1 expression + ER negative + PR negative (0)

PGR positive + HER-2 positive (0)

HR positive (184)

HR negative (25)

ER positive + PGR positive (12)

HR positive + HER-2 negative (5)

ER positive + PGR negative (2)

FGFR1 overexpression + HR positive (2)

HR negative + PD-L1 expression (2)

HR positive + ER overexpression (2)

HR positive + HER-2 underexpression (2)

PGR expression (2)

PGR overexpression (2)

CETN2 overexpression + HR positive (1)

CETN2 overexpression + MLH3 overexpression + PCNA overexpression + HR positive (1)

ER positive + CDK6 overexpression (1)

ER positive + PGR negative + HER-2 negative (1)

HDC overexpression + HR positive (1)

HR overexpression (1)

HR positive + AR positive (1)

HR positive + BRCA positive (1)

HR positive + CCNE1 overexpression (1)

HR positive + ERBB3 overexpression (1)

HR positive + ERBB3 underexpression (1)

HR positive + HER-2 positive (1)

HR positive + PD-L1 expression (1)

HR positive + PLK1 overexpression (1)

HR positive + TNFRSF11A overexpression (1)

MLH3 overexpression + HR positive (1)

NOTCH3 expression + ER positive + PGR positive (1)

PCNA overexpression + HR positive (1)

PGR negative (1)

RAD51 overexpression + HR positive (1)

RFC3 overexpression + ER positive (1)

TNFRSF1A overexpression + HR positive (1)

TYMS overexpression + HR positive (1)

ER negative + PGR positive (0)

ER positive + PGR positive + HER-2 positive (0)

HER-2 negative + PGR positive (0)

HR negative + HER-2 positive (0)

MIEN1 expression + ER negative + PR negative (0)

PGR positive + HER-2 positive (0)

›

PGR positive	Uterine Corpus Leiomyosarcoma	PGR positive	Uterine Corpus Leiomyosarcoma	Aromatase inhibitor Sensitive: A2 - Guideline Aromatase inhibitor Sensitive : A2	Aromatase inhibitor Sensitive: A2 - Guideline Aromatase inhibitor Sensitive : A2
PGR positive	HER2 Negative Breast Cancer	PGR positive	HER2 Negative Breast Cancer	anastrozole Sensitive: A2 - Guideline anastrozole Sensitive : A2	anastrozole Sensitive: A2 - Guideline anastrozole Sensitive : A2
PGR positive	HER2 Negative Breast Cancer	PGR positive	HER2 Negative Breast Cancer	letrozole Sensitive: A2 - Guideline letrozole Sensitive : A2	letrozole Sensitive: A2 - Guideline letrozole Sensitive : A2
PGR positive	Uterine Corpus Leiomyosarcoma	PGR positive	Uterine Corpus Leiomyosarcoma	medroxyprogesterone Sensitive: A2 - Guideline medroxyprogesterone Sensitive : A2	medroxyprogesterone Sensitive: A2 - Guideline medroxyprogesterone Sensitive : A2
PGR positive	Uterine Corpus Leiomyosarcoma	PGR positive	Uterine Corpus Leiomyosarcoma	megestrol Sensitive: A2 - Guideline megestrol Sensitive : A2	megestrol Sensitive: A2 - Guideline megestrol Sensitive : A2
PGR positive	HER2 Positive Breast Cancer	PGR positive	HER2 Positive Breast Cancer	trastuzumab Sensitive: B - Late Trials trastuzumab Sensitive : B	trastuzumab Sensitive: B - Late Trials trastuzumab Sensitive : B
PGR positive	Uterine Cancer	PGR positive	Uterine Cancer	anastrozole Sensitive: C2 – Inclusion Criteria anastrozole Sensitive : C2	anastrozole Sensitive: C2 – Inclusion Criteria anastrozole Sensitive : C2
PGR positive	HER2 Positive Breast Cancer	PGR positive	HER2 Positive Breast Cancer	Sensitive: C3 – Early Trials Sensitive : C3	Sensitive: C3 – Early Trials Sensitive : C3
PGR positive	Uterine Corpus Leiomyosarcoma	PGR positive	Uterine Corpus Leiomyosarcoma	anastrozole Sensitive: C3 – Early Trials anastrozole Sensitive : C3	anastrozole Sensitive: C3 – Early Trials anastrozole Sensitive : C3
PGR positive	HER2 Negative Breast Cancer	PGR positive	HER2 Negative Breast Cancer	Aromatase inhibitor Sensitive: C3 – Early Trials Aromatase inhibitor Sensitive : C3	Aromatase inhibitor Sensitive: C3 – Early Trials Aromatase inhibitor Sensitive : C3